# The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients

> **NCT00629252** · NA · TERMINATED · sponsor: **University of Zurich** · enrollment: 14 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Sertindole
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00629252
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Not enough subjects have been recruited in the expected period.
- **Last updated:** 2012-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629252, "The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00629252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*